Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) FCF Margin (2019 - 2026)

Profound Medical has reported FCF Margin over the past 7 years, most recently at 109.85% for Q4 2025.

  • For Q4 2025, FCF Margin rose 3093.0% year-over-year to 109.85%; the TTM value through Dec 2025 reached 237.34%, down 1161.0%, while the annual FY2025 figure was 238.43%, 1884.0% down from the prior year.
  • FCF Margin for Q4 2025 was 109.85% at Profound Medical, up from 181.77% in the prior quarter.
  • Over five years, FCF Margin peaked at 1315.26% in Q4 2022 and troughed at 3981.06% in Q4 2021.
  • A 5-year average of 216.7% and a median of 240.04% in 2021 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: surged 529633bps in 2022 and later crashed -234897bps in 2023.
  • Year by year, FCF Margin stood at 3981.06% in 2021, then skyrocketed by 133bps to 1315.26% in 2022, then crashed by -179bps to 1033.71% in 2023, then soared by 86bps to 140.78% in 2024, then rose by 22bps to 109.85% in 2025.
  • Business Quant data shows FCF Margin for PROF at 109.85% in Q4 2025, 181.77% in Q3 2025, and 621.62% in Q2 2025.